Atlas Trials

Subcutaneous Lidocaine For Cancer-Related Pain

Clinical trial NCT01384877 · COMPLETED

Trial details

NCT number
NCT01384877
Sponsor
British Columbia Cancer Agency
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cancer-related Pain
Start date
2011-12-01
Primary completion
2017-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.